Showing results (131-140 of 232) with videos related to
Sort By:
Pageof 24
Clinical Science (London, England : 1979)|March 1, 1992
Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitisY R Mahida, M Ceska, F Effenberger, et al.Nuclear Medicine Communications|May 1, 1992
Monoclonal antigranulocyte antibody imaging in inflammatory bowel disease: a preliminary reportY R Mahida, A C Perkins, M Frier, et al.Lancet (London, England)|October 15, 1977
Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute strokeS T McCarthy, J J Turner, D Robertson, et al.Journal of Clinical Microbiology|March 13, 1999
Allelic diversity of the Helicobacter pylori vacuolating cytotoxin gene in South Africa: rarity of the vacA s1a genotype and natural occurrence of an s2/m1 alleleD P Letley, A Lastovica, J A Louw, et al.Alimentary Pharmacology & Therapeutics|April 1, 1993
Ileo-caecal ulceration associated with the use of diclofenac slow releaseN Hudson, M J Wilkinson, A J Swannell, et al.Gut|May 1, 1988
Devastating diarrhoea caused by azathioprine: management difficulty in inflammatory bowel diseaseJ Cox, T K Daneshmend, C J Hawkey, et al.Gut|November 15, 2000
Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosaL M Jackson, K C Wu, Y R Mahida, et al.European Journal of Gastroenterology & Hepatology|July 1, 1995
Critical issues in the pathophysiology and management of peptic ulcer diseaseR H Hunt, P Malfertheiner, N D Yeomans, et al.Gut|January 1, 1991
5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel diseaseY R Mahida, C E Lamming, A Gallagher, et al.Alimentary Pharmacology & Therapeutics|August 1, 1996
Enhanced eradication of Helicobacter pylori by pre- versus post-prandial amoxycillin suspension with omeprazole: implications for antibiotic deliveryJ C Atherton, D J Cullen, G E Kirk, et al.Pageof 24